SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-359387
Filing Date
2021-12-16
Accepted
2021-12-16 17:23:04
Documents
10
Period of Report
2021-12-16

Document Format Files

Seq Description Document Type Size
1 6-K d275648d6k.htm 6-K 23370
2 EX-5.1 d275648dex51.htm EX-5.1 22528
3 EX-10.1 d275648dex101.htm EX-10.1 79753
4 EX-10.2 d275648dex102.htm EX-10.2 130815
5 EX-10.3 d275648dex103.htm EX-10.3 196806
6 EX-99.1 d275648dex991.htm EX-99.1 26549
7 EX-99.2 d275648dex992.htm EX-99.2 30875
8 GRAPHIC g275648g03q94.jpg GRAPHIC 3032
9 GRAPHIC g275648g1216161118691.jpg GRAPHIC 4216
10 GRAPHIC g275648g1216161119073.jpg GRAPHIC 3943
  Complete submission text file 0001193125-21-359387.txt   527727
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 211498600
SIC: 2836 Biological Products, (No Diagnostic Substances)